Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Net Cash Flow (2021 - 2026)

bioAffinity Technologies has reported Net Cash Flow over the past 5 years, most recently at -$3.4 million for Q1 2026.

  • Quarterly Net Cash Flow fell 407.34% to -$3.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.7 million through Mar 2026, up 232.12% year-over-year, with the annual reading at $5.3 million for FY2025, 411.4% up from the prior year.
  • Net Cash Flow was -$3.4 million for Q1 2026 at bioAffinity Technologies, down from -$1.2 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $13.3 million in Q3 2022 and troughed at -$3.8 million in Q3 2023.
  • The 5-year median for Net Cash Flow is -$813630.0 (2022), against an average of $115159.7.
  • The largest YoY upside for Net Cash Flow was 15450.34% in 2025 against a maximum downside of 449.69% in 2025.
  • A 5-year view of Net Cash Flow shows it stood at -$1.9 million in 2022, then rose by 9.47% to -$1.7 million in 2023, then soared by 120.66% to $348711.0 in 2024, then crashed by 449.69% to -$1.2 million in 2025, then plummeted by 174.84% to -$3.4 million in 2026.
  • Per Business Quant, the three most recent readings for BIAF's Net Cash Flow are -$3.4 million (Q1 2026), -$1.2 million (Q4 2025), and $6.9 million (Q3 2025).